Martha Hayden-Ledbetter

Author

Pacific Northwest Diabetes Research Institute

Also Known As

M. Hayden-Ledbetter, Martha Hayden-Ledbetter, Martha Hayden‐Ledbetter, Martha S Hayden-Ledbetter, Martha S. Hayden-Ledbetter

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

Pacific Northwest Diabetes Research Institute University of Washington Alexion Pharmaceuticals (United States)Charité - Universitätsmedizin Berlin Humboldt-Universität zu Berlin

About

Martha Hayden-Ledbetter is an author at Pacific Northwest Diabetes Research Institute specializing in cell biology, medicine, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	1.1K
2	Engineering	1	1	83
3	Health Sciences	1	1	39
4	Allergy	1	1	28
5	Biomedical Engineering	1	1	83

Martha Hayden-Ledbetter

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma. Ingegerd Hellström, John Raycraft, Martha Hayden-Ledbetter, PubMed Malignant DiseaseMedicineImmunologyPathologyCancer Cell Biology	2003	718
Characterization of Human Inducible Costimulator Ligand Expression and Function Alexandra Aicher, Martha Hayden-Ledbetter, William Brady, The Journal of Immunology	2000	241
Gene therapy for cancer using single-chain Fv fragments specific for 4-1BB Zhengmao Ye, Ingegerd Hellström, Martha Hayden-Ledbetter, Nature Medicine Gene TherapiesMedicineMolecular BiologyCancer GenomicsGene Vector	2002	155
Targeting CD37-positive lymphoid malignancies with a novel engineered small modular immunopharmaceutical Zhao Xiaobin, Rosa Lapalombella, Trupti Joshi, Blood	2007	137
Cutting Edge: CD83 Regulates the Development of Cellular Immunity Nathalie Scholler, Martha Hayden-Ledbetter, Amber Dahlin, The Journal of Immunology	2002	120
CD83 Is a Sialic Acid-Binding Ig-Like Lectin (Siglec) Adhesion Receptor that Binds Monocytes and a Subset of Activated CD8+ T Cells Nathalie Scholler, Martha Hayden-Ledbetter, Karl-Erik Hellström, The Journal of Immunology	2001	107
Development of a CA125-mesothelin cell adhesion assay as a screening tool for biologics discovery Nathalie Scholler, Barbara Garvik, Martha Hayden-Ledbetter, Cancer Letters MechanobiologyBiologics DiscoveryEngineeringCell AdhesionBioanalysis	2006	83
ICOS Ligand Costimulation Is Required for T-Cell Encephalitogenicity Romeo A. Sporici, Richard L. Beswick, Carolyn von Allmen, Clinical Immunology Icos Ligand CostimulationT-regulatory CellImmunologyAutoimmunityCell Transplantation	2001	78
Tumor Necrosis Factor-α Regulates the Expression of Inducible Costimulator Receptor Ligand on CD34+ Progenitor Cells during Differentiation into Antigen Presenting Cells Günther Richter, Martha Hayden-Ledbetter, Markus Irgang, Journal of Biological Chemistry	2001	48
CD20-Directed Small Modular Immunopharmaceutical, TRU-015, Depletes Normal and Malignant B Cells Martha Hayden-Ledbetter, C. Cerveny, Erik Espling, Clinical Cancer Research	2009	46

Page 1